Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.

Cunard R, Marquez II, Ball ED, Nelson CL, Corringham S, Clopton P, Sanchez AP, Lane T, Ward DM.

Transfusion. 2014 Jul;54(7):1857-63. doi: 10.1111/trf.12529. Epub 2013 Dec 24.

PMID:
24372185
2.

Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.

Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W, Fischer G, Rosenmayr A, Höcker P, Kalhs P.

Transfusion. 2007 Aug;47(8):1494-502.

PMID:
17655594
3.

Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.

Curley C, Pillai E, Mudie K, Western R, Hutchins C, Durrant S, Kennedy GA.

Transfusion. 2012 Feb;52(2):291-7. doi: 10.1111/j.1537-2995.2011.03295.x. Epub 2011 Aug 16.

PMID:
21848968
4.

Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.

Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G, Mayr W, Höcker P, Kalhs P.

Transfusion. 2002 Oct;42(10):1293-301.

PMID:
12423513
5.

Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.

Canals C, Muñiz-Díaz E, Martínez C, Martino R, Moreno I, Ramos A, Arilla M, Boto N, Pastoret C, Remacha A, Sierra J, Madoz P.

Transfusion. 2004 Nov;44(11):1603-11.

PMID:
15504166
6.

After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.

Schetelig J, Breitschaft A, Kröger N, Zabelina T, Ebell W, Bornhäuser M, Haack A, Ehninger G, Salama A, Siegert W; Cooperative Transplantations Study Group..

Transfusion. 2005 May;45(5):779-87.

PMID:
15847669
7.

Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.

Yazer MH, Triulzi DJ.

Curr Opin Hematol. 2007 Nov;14(6):664-70. Review.

PMID:
17898572
8.

Clinical guide to ABO-incompatible allogeneic stem cell transplantation.

Booth GS, Gehrie EA, Bolan CD, Savani BN.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1152-8. doi: 10.1016/j.bbmt.2013.03.018. Epub 2013 Apr 6.

9.

Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.

Watz E, Remberger M, Ringden O, Lundahl J, Ljungman P, Mattsson J, Wikman A, Uhlin M.

Biol Blood Marrow Transplant. 2014 Feb;20(2):264-71. doi: 10.1016/j.bbmt.2013.11.011. Epub 2013 Nov 22.

10.

Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.

Scholl S, Klink A, Mügge LO, Schilling K, Höffken K, Sayer HG.

Transfusion. 2005 Oct;45(10):1676-83. Review.

PMID:
16181220
11.

ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.

Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N, Barlogie B, Cottler-Fox M.

Transfusion. 2002 Feb;42(2):205-9.

PMID:
11896336
12.

Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.

Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF.

Br J Haematol. 2001 Mar;112(3):787-95.

PMID:
11260085
13.

Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.

Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT.

Transplant Proc. 2009 Nov;41(9):3851-8. doi: 10.1016/j.transproceed.2009.06.189.

PMID:
19917400
14.

Passenger lymphocyte syndrome in ABO and Rhesus D minor mismatched liver and kidney transplantation: A prospective analysis.

ElAnsary M, Hanna MO, Saadi G, ElShazly M, Fadel FI, Ahmed HA, Aziz AM, ElSharnouby A, Kandeel MM.

Hum Immunol. 2015 Jun;76(6):447-52. doi: 10.1016/j.humimm.2015.03.006. Epub 2015 Apr 1.

PMID:
25842056
15.

Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

Atay D, Erbey F, Akcay A, Ozturk G.

Pediatr Transplant. 2015 Sep;19(6):645-51. doi: 10.1111/petr.12552. Epub 2015 Jul 8.

PMID:
26156679
16.

Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.

Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE.

Blood. 1992 Jun 1;79(11):3076-85.

17.

ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.

Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A, Mitterbauer M, Mannhalter C, Mayr WR, Schwarzinger I, Höcker P, Lechner K, Greinix HT.

Transfusion. 2003 Aug;43(8):1153-61.

PMID:
12869124
18.

Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.

Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD.

Xenotransplantation. 2006 Mar;13(2):126-32.

PMID:
16623806
19.

Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.

Marenchino D, Maddalena L, Balbo R, Avonto I, Menardi G, Prucca M, Perotti L, Mordini N, Peano G.

Blood Transfus. 2011 Jan;9(1):79-85. doi: 10.2450/2010.0020-10. Epub 2010 May 19.

20.

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.

Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T, Storb R, Torok-Storb B.

Br J Haematol. 2002 Dec;119(3):740-50.

PMID:
12437653

Supplemental Content

Support Center